Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-20, Stock:LLY, The news for the past five days is as follows:
2018-08-13: NEWS1: Mylan Launches First Adcirca Generic, Stock Moves Up.NEWS2: Novo Nordisk’s Long-Acting Insulins: A Performance Overview.NEWS3: Can Victoza Continue to Boost Novo Nordisk’s Revenue Growth?.NEWS4: Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings.NEWS5: Here's Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings.NEWS6: Novo Nordisk: A Financial Overview after the First Half of 2018.NEWS7: Here&apos;s Why Lilly (LLY) Stock is Up 15% Since Q2 Earnings.NEWS8: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for August 14, 2018.NEWS9: Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for August 14, 2018.
2018-08-14: NEWS1: Analyzing Nektar Therapeutics’ Financial Performance.NEWS2: Pfizer Is Expected to Report Modest Revenue Rise in Fiscal 2018.NEWS3: Novo Nordisk’s Fast-Acting Insulins: A Performance Overview.
2018-08-15: NEWS1: [$$] Karuna Appoints Steven Paul as CEO.NEWS2: Health Care Sector Update for 08/15/2018: ICPT,CGC,WEED.TO,STZ,LLY,EARS.NEWS3: Health Care Sector Update for 08/15/2018: ICPT,CGC,WEED.TO,STZ,LLY,EARS.NEWS4: Health Care Sector Update for 08/15/2018: LLY,EARS.NEWS5: Health Care Sector Update for 08/15/2018: LLY,EARS.NEWS6: What Does Nektar Therapeutics’ Valuation Trend Indicate?.NEWS7: Elanco Animal Health Announces Pricing of $2.0 Billion of Senior Notes.
2018-08-16: NEWS1: Eli Lilly's Overbought Stock Poised to Fall 15%.NEWS2: A Look at the Performance of Bausch Health’s Ortho Dermatologics.
2018-08-17: NEWS1: Should you trade or fade this week's biggest winners?.NEWS2: Lilly (LLY) Hits 52-Week High, Can the Run Continue?.NEWS3: Lilly (LLY) Hits 52-Week High, Can the Run Continue?.NEWS4: Pharma Stock Roundup: Blow for Bayer, FDA Nod for MRK Cancer Drug in New Indication.NEWS5: Pharma Stock Roundup: Blow for Bayer, FDA Nod for MRK Cancer Drug in New Indication.NEWS6: Lilly (LLY) Hits 52-Week High, Can the Run Continue?.NEWS7: The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns.

Answer: Rise